It showed promising results with a dose–response increased probability of improvement in at least one stage in fibrosis, which was associated with an improvement in glucose control and adipocyte function (expressed as an increase in adiponectin), without an increase in body weight or peripheral edema (141). This evidence concerns the gene ADIPOQ and fibrosis.